We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.61%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$43.5B
AUM Growth
+$8.16B
(+23%)
Cap. Flow
+$4.5B
Cap. Flow
% of AUM
10.34%
Top 10 Holdings %
Top 10 Hldgs %
11.55%
Holding
3,819
New
249
Increased
1,063
Reduced
1,013
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$424M |
| 2 |
Kenvue
KVUE
|
+$415M |
| 3 |
Cummins
CMI
|
+$374M |
| 4 |
Bunge Global
BG
|
+$310M |
| 5 |
Newell Brands
NWL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$423M |
| 2 |
Qualcomm
QCOM
|
+$413M |
| 3 |
D.R. Horton
DHI
|
+$401M |
| 4 |
Booking.com
BKNG
|
+$397M |
| 5 |
Phillips 66
PSX
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Energy | 16.95% |
| 3 | Industrials | 12.39% |
| 4 | Healthcare | 10.91% |
| 5 | Technology | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
AnaptysBio
ANAB
$1.54B
| $9.5K | ﹤0.01% |
+422
| New | +$9.99K |
|
1402
SGHC Ltd
SGHC
$7.62B
| $9.15K | ﹤0.01% |
2,651
-21
| -0.8% | -$67 |
|
|
NGMS
1403
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $8.57K | ﹤0.01% |
296
+24
| +9% | +$680 |
|
1404
Tango Therapeutics
TNGX
$4.34B
| $8.12K | ﹤0.01% |
+1,022
| New | +$11K |
|
1405
Alector
ALEC
$169M
| $7.75K | ﹤0.01% |
+1,288
| New | +$8.42K |
|
|
MRSN
1406
DELISTED
Mersana Therapeutics
MRSN
| $7.69K | ﹤0.01% |
+69
| New | +$6.86K |
|
1407
Cullinan Oncology
CGEM
$1.07B
| $7.67K | ﹤0.01% |
+450
| New | +$6.95K |
|
1408
iShares MSCI Brazil ETF
EWZ
$9.13B
| $7.49K | ﹤0.01% |
231
-8
| -3% | -$265 |
|
|
FIRY
1409
Firy Inc
FIRY
$154M
| $7.24K | ﹤0.01% |
1,115
+148
| +15% | +$908 |
|
1410
Oric Pharmaceuticals
ORIC
$1.23B
| $7.09K | ﹤0.01% |
+516
| New | +$6.13K |
|
|
MTLS
1411
Materialise
MTLS
$373M
| $5.75K | ﹤0.01% |
1,090
+1
| +0.1% | +$6 |
|
1412
iShares MSCI UAE ETF
UAE
$309M
| $5.72K | ﹤0.01% |
387
-84
| -18% | -$1.24K |
|
1413
Organon & Co
OGN
$3.55B
| $5.68K | ﹤0.01% |
302
| – | – |
|
1414
Nextpower Inc
NXT
$14.5B
| $5.63K | ﹤0.01% |
+100
| New | +$5.32K |
|
1415
ARS Pharmaceuticals
SPRY
$563M
| $5.27K | ﹤0.01% |
+516
| New | +$3.85K |
|
1416
Voyager Therapeutics
VYGR
$184M
| $5.16K | ﹤0.01% |
+554
| New | +$4.68K |
|
1417
Full Truck Alliance
YMM
$9.64B
| $5.06K | ﹤0.01% |
696
-62
| -8% | -$414 |
|
|
CRGX
1418
DELISTED
CARGO Therapeutics
CRGX
| $5.02K | ﹤0.01% |
+225
| New | +$5.35K |
|
1419
Fortrea Holdings
FTRE
$1.96B
| $4.21K | ﹤0.01% |
105
| – | – |
|
|
ALTR
1420
DELISTED
Altair Engineering Inc
ALTR
| $3.96K | ﹤0.01% |
46
| – | – |
|
1421
Avita Medical
RCEL
$142M
| $3.91K | ﹤0.01% |
+244
| New | +$3.95K |
|
1422
Symbotic
SYM
$5.39B
| $3.06K | ﹤0.01% |
68
+4
| +6% | +$175 |
|
1423
Matsons
MATX
$6.15B
| $3.04K | ﹤0.01% |
27
-1
| -4% | -$113 |
|
1424
Sanmina
SANM
$9.24B
| $2.55K | ﹤0.01% |
41
-4
| -9% | -$233 |
|
1425
Stepan Co
SCL
$1.32B
| $2.43K | ﹤0.01% |
27
| – | – |
|
Similar funds
SAM
Pacer Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Pacer Advisors held 3,819 positions worth $43.5B, up 23% from $35.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pacer Advisors deployed $4.5B of net new capital in Q1 2024, opening 249 new positions and adding to 1,063 existing holdings. Its largest new stake was Hanesbrands: 32,772,533 shares worth $190M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 19% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $423M trimmed.
- Pacer Advisors's largest Q1 2024 buy was Hanesbrands: 32,772,533 shares worth $190M.
- Pacer Advisors added most to AT&T in Q1 2024, an estimated $424M increase.
- Pacer Advisors's biggest Q1 2024 reduction was AbbVie, cutting an estimated $423M.
- Pacer Advisors fully exited Tri Pointe Homes in Q1 2024, selling an estimated $139M.
- Pacer Advisors's ten largest holdings make up 12% of its $43.5B portfolio in Q1 2024.
- Pacer Advisors opened 249 new positions and closed 119 in Q1 2024.
- Pacer Advisors's portfolio value rose 23% quarter-over-quarter to $43.5B.
Based on Pacer Advisors's 13F filing for Q1 2024, filed 10 May 2024.